Skip to main content
. 2023 Jun 30;28(2):64–74. doi: 10.15430/JCP.2023.28.2.64

Table 6. Evaluation of ER, PR, and HER2 using endpoint RT-PCR (n = 41).

Variable Endpoint RT-PCR Frequency
ER Positive 29 (70.7)
Negative 12 (29.3)
PR Positive 5 (12.2)
Negative 36 (87.8)
HER2 Positive 9 (22.0)
Negative 32 (78.0)

Values are presented as number (%). RT-PCR, reverse transcription PCR; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2.